William Woods
Stock Analyst at B. Riley Securities
(1.50)
# 3,566
Out of 5,139 analysts
12
Total ratings
46.15%
Success rate
-5.95%
Average return
Main Sectors:
Stocks Rated by William Woods
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PALI Palisade Bio | Initiates: Buy | $7 | $1.66 | +321.69% | 1 | Jan 9, 2026 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Buy | $560 → $670 | $501.68 | +33.55% | 1 | Dec 11, 2025 | |
| OKYO OKYO Pharma | Initiates: Buy | $5 | $2.21 | +126.24% | 1 | Dec 8, 2025 | |
| CGTX Cognition Therapeutics | Reiterates: Buy | $2 → $3 | $1.46 | +105.48% | 1 | Nov 21, 2025 | |
| LFMD LifeMD | Maintains: Buy | $12 → $10 | $3.77 | +165.25% | 3 | Nov 18, 2025 | |
| IMUX Immunic | Reiterates: Buy | $6 → $5 | $0.62 | +709.06% | 3 | May 23, 2025 | |
| VERU Veru Inc. | Initiates: Buy | $50 | $2.69 | +1,758.74% | 1 | May 14, 2024 | |
| KRMD KORU Medical Systems | Reiterates: Buy | $4 | $5.51 | -27.40% | 1 | Mar 14, 2024 |
Palisade Bio
Jan 9, 2026
Initiates: Buy
Price Target: $7
Current: $1.66
Upside: +321.69%
Madrigal Pharmaceuticals
Dec 11, 2025
Maintains: Buy
Price Target: $560 → $670
Current: $501.68
Upside: +33.55%
OKYO Pharma
Dec 8, 2025
Initiates: Buy
Price Target: $5
Current: $2.21
Upside: +126.24%
Cognition Therapeutics
Nov 21, 2025
Reiterates: Buy
Price Target: $2 → $3
Current: $1.46
Upside: +105.48%
LifeMD
Nov 18, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $3.77
Upside: +165.25%
Immunic
May 23, 2025
Reiterates: Buy
Price Target: $6 → $5
Current: $0.62
Upside: +709.06%
Veru Inc.
May 14, 2024
Initiates: Buy
Price Target: $50
Current: $2.69
Upside: +1,758.74%
KORU Medical Systems
Mar 14, 2024
Reiterates: Buy
Price Target: $4
Current: $5.51
Upside: -27.40%